D-1325-2015 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-1325-2015 was initiated by Dr. Reddy's Laboratories, Inc. on Aug 3, 2015 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Mar 24, 2017). Affected quantity: 2,952 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 19, 2015
Initiation Date
Aug 3, 2015
Termination Date
Mar 24, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,952 bottles

Product description

Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-352-60

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

Lot #: C501342; Exp 01/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1325-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1325-2015. Report a data issue: hello@regdatalab.com.